SUMMARY OF BASIC LEASE INFORMATIONLease • March 6th, 2019 • Unity Biotechnology, Inc. • Pharmaceutical preparations • California
Contract Type FiledMarch 6th, 2019 Company Industry Jurisdiction
Compound License Agreement for APG1197Stock Issuance Agreement • March 6th, 2019 • Unity Biotechnology, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 6th, 2019 Company Industry JurisdictionThis Compound License Agreement (the “Agreement”) effective as of the 2nd day of January, 2019, (the “Effective Date”) is made by and between Ascentage Pharma Group Corp. Ltd., a Hong Kong corporation and its affiliates (collectively, “Ascentage”), with a business address at 11/F, AXA CENTRE, Gloucester Road, Wanchai, Hong Kong, and Unity Biotechnology, Inc., a Delaware corporation (“Unity”), with a business address at 3280 Bayshore Blvd, Suite 100, Brisbane, California 94005. Each of Ascentage and Unity shall be a “Party,” and both the “Parties.”